170 related articles for article (PubMed ID: 9510444)
21. P2RY12:rs7637803 TT variant genotype increases coronary artery aneurysm risk in Kawasaki disease in a southern Chinese population.
Lu Z; Xu Y; Fu L; Tan Y; Che D; Huang P; Pi L; Zhou H; Liang X; Zhang L; Gu X
J Gene Med; 2019 Jan; 21(1):e3066. PubMed ID: 30576025
[TBL] [Abstract][Full Text] [Related]
22. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
23. A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan.
Nakamura Y; Yanagawa H
Eur J Pediatr; 1996 Apr; 155(4):303-7. PubMed ID: 8777924
[TBL] [Abstract][Full Text] [Related]
24. Cardiac sequelae in recurrent cases of Kawasaki disease: a comparison between the initial episode of the disease and a recurrence in the same patients.
Nakamura Y; Oki I; Tanihara S; Ojima T; Yanagawa H
Pediatrics; 1998 Dec; 102(6):E66. PubMed ID: 9832594
[TBL] [Abstract][Full Text] [Related]
25. [Kawasaki disease: heart disease during childhood].
Schroh AM; Domínguez P; Laghezza LB; Melonari PA; Olguín M; Miatello R
Rev Esp Cardiol; 2006 Apr; 59(4):387-90. PubMed ID: 16709393
[TBL] [Abstract][Full Text] [Related]
26. Transformation of coronary artery aneurysm to obstructive lesion and the role of collateral vessels in myocardial perfusion in patients with Kawasaki disease.
Onouchi Z; Hamaoka K; Kamiya Y; Hayashi S; Ohmochi Y; Sakata K; Shiraishi I; Hayano T; Fukumochi H
J Am Coll Cardiol; 1993 Jan; 21(1):158-62. PubMed ID: 8417058
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of a Kawasaki Disease Risk Model for Predicting Coronary Artery Aneurysms in a Japanese Population: An Analysis of Post RAISE.
Miyata K; Miura M; Kaneko T; Morikawa Y; Matsushima T; Sakakibara H; Misawa M; Kobayashi T; Yamagishi H
J Pediatr; 2021 Oct; 237():96-101.e3. PubMed ID: 34147499
[TBL] [Abstract][Full Text] [Related]
28. Kawasaki disease incidence in children and adolescents: an observational study in primary care.
Hall GC; Tulloh LE; Tulloh RM
Br J Gen Pract; 2016 Apr; 66(645):e271-6. PubMed ID: 26906631
[TBL] [Abstract][Full Text] [Related]
29. Giant aneurysms: A gender-specific complication of Kawasaki disease?
Dietz SM; Kuipers IM; Tacke CEA; Koole JCD; Hutten BA; Kuijpers TW
J Cardiol; 2017 Oct; 70(4):359-365. PubMed ID: 28325522
[TBL] [Abstract][Full Text] [Related]
30. Effects of gamma-globulin on the cardiac sequelae of Kawasaki disease.
Yanagawa H; Tuohong Z; Oki I; Nakamura Y; Yashiro M; Ojima T; Tanihara S
Pediatr Cardiol; 1999; 20(4):248-51. PubMed ID: 10368448
[TBL] [Abstract][Full Text] [Related]
31. Kawasaki disease: a clinical and epidemiological study of 70 children in Brazil.
Magalhães CM; Vasconcelos PA; Pereira MR; Alves NR; Gandolfi L; Pratesi R
Trop Doct; 2009 Apr; 39(2):99-101. PubMed ID: 19299294
[TBL] [Abstract][Full Text] [Related]
32. Kawasaki disease in Jordan: demographics, presentation, and outcome.
Al-Ammouri I; Al-Wahsh S; Khuri-Bulos N
Cardiol Young; 2012 Aug; 22(4):390-5. PubMed ID: 22067065
[TBL] [Abstract][Full Text] [Related]
33. A retrospective cohort study of major adverse cardiac events in children affected by Kawasaki disease with coronary artery aneurysms in Thailand.
Santimahakullert K; Vijarnsorn C; Wongswadiwat Y; Chanthong P; Khrongsrattha S; Panamonta M; Chan-On P; Durongpisitkul K; Chungsomprasong P; Kanjanauthai S; Soongswang J
PLoS One; 2022; 17(1):e0263060. PubMed ID: 35085339
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China.
Ruan Y; Ye B; Zhao X
Pediatr Infect Dis J; 2013 Oct; 32(10):e397-402. PubMed ID: 23722531
[TBL] [Abstract][Full Text] [Related]
35. Giant coronary aneurysms developed in a child of Kawasaki disease with only 3 days of fever.
Lin MC; Hsu CM; Fu YC
Cardiol Young; 2010 Jun; 20(3):339-41. PubMed ID: 20307334
[TBL] [Abstract][Full Text] [Related]
36. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
[TBL] [Abstract][Full Text] [Related]
37. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population.
Son MBF; Gauvreau K; Tremoulet AH; Lo M; Baker AL; de Ferranti S; Dedeoglu F; Sundel RP; Friedman KG; Burns JC; Newburger JW
J Am Heart Assoc; 2019 Jun; 8(11):e011319. PubMed ID: 31130036
[TBL] [Abstract][Full Text] [Related]
38. Lack of value of procalcitonin for prediction of coronary aneurysms in Kawasaki disease.
Catalano-Pons C; André MC; Chalumeau M; Guérin S; Gendrel D
Pediatr Infect Dis J; 2007 Feb; 26(2):179-80. PubMed ID: 17259884
[TBL] [Abstract][Full Text] [Related]
39. [Kawasaki disease in children--9 years experience].
Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
[TBL] [Abstract][Full Text] [Related]
40. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy.
Rowley AH; Duffy CE; Shulman ST
J Pediatr; 1988 Aug; 113(2):290-4. PubMed ID: 2456378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
